Tag: postpartum depression market segments

Uncover key drivers, emerging technologies, and competitive movements shaping the postpartum depression market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Postpartum Depression Market size between 2026 and 2035?

The postpartum depression market size has undergone substantial expansion in recent years. It is anticipated to grow from $16.05 billion in 2025 to $21.17 billion in 2026, at a compound annual growth rate (CAGR) of 31.9%. The historical growth of this market can be attributed to several factors, including the increasing recognition of maternal mental health disorders, limited early screening practices, prevalent underdiagnosis in postpartum care settings, a reliance on traditional counseling approaches, and the growth of hospital-based maternal care services.

The postpartum depression market size is anticipated to experience substantial growth over the upcoming years, projected to reach $66.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 33.1%. This expansion during the forecast period is propelled by factors such as the greater uptake of digital screening instruments, an increased emphasis on proactive maternal healthcare, the widening availability of tele-mental health services, rising investments in women’s mental well-being initiatives, and the deeper incorporation of mental health support into obstetric care. Key developments expected in this period encompass heightened public awareness and screening for postpartum mental health, greater acceptance of digital platforms for mental wellness, a stronger focus on prompt diagnosis and intervention, the extension of community-based assistance programs, and improved integration of mental health services within maternal care pathways.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

Which Drivers Are Impacting Market Performance In The Postpartum Depression Market?

An increasing number of childbirths is anticipated to fuel the expansion of the postpartum depression market. Childbirth describes the natural process of a baby exiting the mother’s uterus, typically through the vaginal canal. This rise in births contributes to the postpartum depression market because postpartum depression (PPD) is a prevalent mental health condition affecting women post-delivery, manifesting in symptoms such as sadness, anxiety, fatigue, and challenges in maternal-infant bonding. As an illustration, a report from the Centers for Disease Control and Prevention, a US-based national public health organization, indicated that in January 2023, the United States experienced a 1% rise in recorded births, reaching a total of 3,664,292, relative to the prior year. Consequently, the increasing volume of childbirths is stimulating growth within the postpartum depression market.

What Segment Types Are Examined In The Postpartum Depression Market?

The postpartum depression market covered in this report is segmented –

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types

2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings

7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Which Trends Are Influencing The Development Of The Postpartum Depression Market?

Major companies operating in the postpartum depression market are focusing on new product innovations, including regulatory milestones to advance the development and potential approval pathway of zuranolone for major depressive disorder and postpartum depression. A regulatory milestone denotes a crucial event in a drug or medical product’s lifecycle, signaling progress within the approval or compliance framework established by governmental authorities. For instance, in February 2023, Biogen Inc., a US-based biotechnology company, and Sage Therapeutics Inc., a US-based biopharmaceutical company, announced that the United States Food and Drug Administration (FDA) had accepted the submission of a New Drug Application (NDA) for zuranolone for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational medication being evaluated as a 14-day, once-daily, rapid-acting oral therapy for individuals with MDD and PPD. This neuroactive steroid functions as a positive allosteric modulator of GABA-A receptors, representing a distinct mechanism of action. It is designed to work in persons with depression by quickly resetting dysregulated neural networks to help restore brain function. Zuranolone influences brain networks responsible for mood, arousal, behavior, and cognition.

Who Are The Core Companies Influencing Trends In The Postpartum Depression Market?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals plc, Sage Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Lundbeck A S, Janssen Pharmaceuticals, Aurobindo Pharma Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Which Regions Are Projected To Dominate The Postpartum Depression Market In The Coming Years?

North America was the largest region in the postpartum depression market in 2025. The regions covered in the postpartum depression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Postpartum Depression Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

Browse Through More Reports Similar to the Global Postpartum Depression Market 2026, By The Business Research Company

Antidepressant Market Report 2026

https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

Postpartum Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/postpartum-health-supplements-global-market-report

Major Depressive Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the postpartum depression market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Postpartum Depression Market size between 2026 and 2035?

The postpartum depression market size has undergone substantial expansion in recent years. It is anticipated to grow from $16.05 billion in 2025 to $21.17 billion in 2026, at a compound annual growth rate (CAGR) of 31.9%. The historical growth of this market can be attributed to several factors, including the increasing recognition of maternal mental health disorders, limited early screening practices, prevalent underdiagnosis in postpartum care settings, a reliance on traditional counseling approaches, and the growth of hospital-based maternal care services.

The postpartum depression market size is anticipated to experience substantial growth over the upcoming years, projected to reach $66.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 33.1%. This expansion during the forecast period is propelled by factors such as the greater uptake of digital screening instruments, an increased emphasis on proactive maternal healthcare, the widening availability of tele-mental health services, rising investments in women’s mental well-being initiatives, and the deeper incorporation of mental health support into obstetric care. Key developments expected in this period encompass heightened public awareness and screening for postpartum mental health, greater acceptance of digital platforms for mental wellness, a stronger focus on prompt diagnosis and intervention, the extension of community-based assistance programs, and improved integration of mental health services within maternal care pathways.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

Which Drivers Are Impacting Market Performance In The Postpartum Depression Market?

An increasing number of childbirths is anticipated to fuel the expansion of the postpartum depression market. Childbirth describes the natural process of a baby exiting the mother’s uterus, typically through the vaginal canal. This rise in births contributes to the postpartum depression market because postpartum depression (PPD) is a prevalent mental health condition affecting women post-delivery, manifesting in symptoms such as sadness, anxiety, fatigue, and challenges in maternal-infant bonding. As an illustration, a report from the Centers for Disease Control and Prevention, a US-based national public health organization, indicated that in January 2023, the United States experienced a 1% rise in recorded births, reaching a total of 3,664,292, relative to the prior year. Consequently, the increasing volume of childbirths is stimulating growth within the postpartum depression market.

What Segment Types Are Examined In The Postpartum Depression Market?

The postpartum depression market covered in this report is segmented –

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types

2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings

7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Which Trends Are Influencing The Development Of The Postpartum Depression Market?

Major companies operating in the postpartum depression market are focusing on new product innovations, including regulatory milestones to advance the development and potential approval pathway of zuranolone for major depressive disorder and postpartum depression. A regulatory milestone denotes a crucial event in a drug or medical product’s lifecycle, signaling progress within the approval or compliance framework established by governmental authorities. For instance, in February 2023, Biogen Inc., a US-based biotechnology company, and Sage Therapeutics Inc., a US-based biopharmaceutical company, announced that the United States Food and Drug Administration (FDA) had accepted the submission of a New Drug Application (NDA) for zuranolone for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational medication being evaluated as a 14-day, once-daily, rapid-acting oral therapy for individuals with MDD and PPD. This neuroactive steroid functions as a positive allosteric modulator of GABA-A receptors, representing a distinct mechanism of action. It is designed to work in persons with depression by quickly resetting dysregulated neural networks to help restore brain function. Zuranolone influences brain networks responsible for mood, arousal, behavior, and cognition.

Who Are The Core Companies Influencing Trends In The Postpartum Depression Market?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals plc, Sage Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Lundbeck A S, Janssen Pharmaceuticals, Aurobindo Pharma Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Which Regions Are Projected To Dominate The Postpartum Depression Market In The Coming Years?

North America was the largest region in the postpartum depression market in 2025. The regions covered in the postpartum depression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Postpartum Depression Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

Browse Through More Reports Similar to the Global Postpartum Depression Market 2026, By The Business Research Company

Antidepressant Market Report 2026

https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

Postpartum Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/postpartum-health-supplements-global-market-report

Major Depressive Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the postpartum depression market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Postpartum Depression Market size between 2026 and 2035?

The postpartum depression market size has undergone substantial expansion in recent years. It is anticipated to grow from $16.05 billion in 2025 to $21.17 billion in 2026, at a compound annual growth rate (CAGR) of 31.9%. The historical growth of this market can be attributed to several factors, including the increasing recognition of maternal mental health disorders, limited early screening practices, prevalent underdiagnosis in postpartum care settings, a reliance on traditional counseling approaches, and the growth of hospital-based maternal care services.

The postpartum depression market size is anticipated to experience substantial growth over the upcoming years, projected to reach $66.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 33.1%. This expansion during the forecast period is propelled by factors such as the greater uptake of digital screening instruments, an increased emphasis on proactive maternal healthcare, the widening availability of tele-mental health services, rising investments in women’s mental well-being initiatives, and the deeper incorporation of mental health support into obstetric care. Key developments expected in this period encompass heightened public awareness and screening for postpartum mental health, greater acceptance of digital platforms for mental wellness, a stronger focus on prompt diagnosis and intervention, the extension of community-based assistance programs, and improved integration of mental health services within maternal care pathways.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

Which Drivers Are Impacting Market Performance In The Postpartum Depression Market?

An increasing number of childbirths is anticipated to fuel the expansion of the postpartum depression market. Childbirth describes the natural process of a baby exiting the mother’s uterus, typically through the vaginal canal. This rise in births contributes to the postpartum depression market because postpartum depression (PPD) is a prevalent mental health condition affecting women post-delivery, manifesting in symptoms such as sadness, anxiety, fatigue, and challenges in maternal-infant bonding. As an illustration, a report from the Centers for Disease Control and Prevention, a US-based national public health organization, indicated that in January 2023, the United States experienced a 1% rise in recorded births, reaching a total of 3,664,292, relative to the prior year. Consequently, the increasing volume of childbirths is stimulating growth within the postpartum depression market.

What Segment Types Are Examined In The Postpartum Depression Market?

The postpartum depression market covered in this report is segmented –

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types

2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings

7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Which Trends Are Influencing The Development Of The Postpartum Depression Market?

Major companies operating in the postpartum depression market are focusing on new product innovations, including regulatory milestones to advance the development and potential approval pathway of zuranolone for major depressive disorder and postpartum depression. A regulatory milestone denotes a crucial event in a drug or medical product’s lifecycle, signaling progress within the approval or compliance framework established by governmental authorities. For instance, in February 2023, Biogen Inc., a US-based biotechnology company, and Sage Therapeutics Inc., a US-based biopharmaceutical company, announced that the United States Food and Drug Administration (FDA) had accepted the submission of a New Drug Application (NDA) for zuranolone for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational medication being evaluated as a 14-day, once-daily, rapid-acting oral therapy for individuals with MDD and PPD. This neuroactive steroid functions as a positive allosteric modulator of GABA-A receptors, representing a distinct mechanism of action. It is designed to work in persons with depression by quickly resetting dysregulated neural networks to help restore brain function. Zuranolone influences brain networks responsible for mood, arousal, behavior, and cognition.

Who Are The Core Companies Influencing Trends In The Postpartum Depression Market?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals plc, Sage Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Lundbeck A S, Janssen Pharmaceuticals, Aurobindo Pharma Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Which Regions Are Projected To Dominate The Postpartum Depression Market In The Coming Years?

North America was the largest region in the postpartum depression market in 2025. The regions covered in the postpartum depression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Postpartum Depression Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

Browse Through More Reports Similar to the Global Postpartum Depression Market 2026, By The Business Research Company

Antidepressant Market Report 2026

https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

Postpartum Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/postpartum-health-supplements-global-market-report

Major Depressive Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Future Growth Projections For The Postpartum Depression Market Size?

The market size for postpartum depression has seen an exponential increase of late. The market value is projected to escalate from $12.15 billion in 2024 to reach $16.05 billion by 2025, with a compound annual growth rate (CAGR) amounting to 32.1%. Factors contributing to this growth within the historical timeframe include widely spread knowledge on maternal mental health, advancements in research, the implementation of public health strategies, and augmented screening processes.

The market size for postpartum depression is projected to witness incredible expansion in the forthcoming years, increasing to $49.49 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 32.5%. This predicted rise during the forecast period can be credited to factors such as the usage of telehealth services, advancements in pharmacology, enactments related to maternal mental health, and the expansion of the mental health workforce. Significant trends anticipated during the forecast period comprise of integrated care models, peer support programs, apps focused on perinatal mental health, and tools for mental health screening.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

Which Factors Are Steering Growth In The Postpartum Depression Market?

The growth of the postpartum depression market is anticipated to be driven by a rise in cases of postpartum depression. This condition, characterized by amplified anxiety following childbirth, can present physical symptoms as well. Postnatal depression and postpartum anxiety often coexist, and symptoms can emerge at any point in the first year after birth. Popular treatments include psychotherapy — also known as talk therapy or mental health counselling — medication, or a combination of both, contributing to the expansion of the market. In a February 2022 study by the University of Virginia School of Medicine (UVA SoM), a survey of 1.1 million moms revealed that postpartum depression risk is highest amongst first-time mothers, those under 25, and mothers of twins. The data showed the highest self-reported postpartum depression symptom rate of 10% among women aged 18-24. Mothers of twins had higher rates of postpartum depression, with 11.3% showing symptoms, in contrast to 8.3% of single-child mothers. Hence, the surge in postpartum depression cases is anticipated to fuel the postpartum depression market.

How Is The Postpartum Depression Market Organized By Different Segments?

The postpartum depressionmarket covered in this report is segmented –

1) By Types: Postpartum Blues; Postpartum Anxiety; Postpartum Obsessive Compulsive Disorder; Postpartum Panic Disorder; Postpartum Post-Traumatic Stress Disorder; Postpartum Psychosis; Other Types

2) By Treatment: Psychotherapy; Medication; Supplements; Other Treatments

3) By Route of Administration: Oral; Parenteral; Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances; Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD); Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts; Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks; Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth; Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations; Severe Mood Swings

7) By Other Types: Mixed Mood Disorders; Comorbid Conditions With Postpartum

What Key Trends Are Driving Growth In The Postpartum Depression Market?

Companies in the postpartum depression market are focusing on novel product advancements to maintain market dominance. The scarcity of treatment options has driven a growing demand for innovative, more rapid therapies and creative care approaches for postpartum depression. For example, in February 2023, American biotechnology firm, Biogen Inc., and biopharmaceutical corporation, Sage Therapeutics Inc., declared that the US Food and Drug Administration (FDA) has approved the filing of a new drug application (NDA) for zuranolone in treating major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is a trial drug being examined as a 14-day, single daily, quick-acting oral remedy for individuals with MDD and PPD. This neuroactive steroid functions as a positive allosteric modulator of GABA-A receptors, displaying a unique mode of action. It’s hypothesized to work in depression sufferers by promptly adjusting dysregulated neural circuits to aid in the restoration of brain function. It’s believed that zuranolone influences brain networks governing mood, arousal, conduct, and even cognitive abilities.

Who Are The Most Influential Companies In The Postpartum Depression Market?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Which Region Dominates The Postpartum Depression Market Today?

North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

Browse Through More Reports Similar to the Global Postpartum Depression Market 2025, By The Business Research Company

Mental Health Apps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mental-health-apps-global-market-report

Behavioral And Mental Health Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Residential Substance Abuse And Mental Health Facilities Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Postpartum Depression Market Expected To Become By 2029 Compared With Its 2025 Level?

The postpartum depression market has experienced substantial growth in recent years. Its value is projected to climb from $12.15 billion in 2024 to $16.05 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 32.1%. This expansion in the past can be linked to greater maternal mental health awareness, progress in research, various public health programs, and an increase in screening procedures.

The postpartum depression market is anticipated to experience substantial growth in the upcoming years. It is projected to reach $49.49 billion by 2029, with a compound annual growth rate (CAGR) of 32.5%. This expansion during the forecast period is driven by factors such as telehealth services, pharmacological advancements, maternal mental health legislation, and the expansion of the mental health workforce. Prominent trends for this period include integrated care models, peer support programs, perinatal mental health apps, and mental health screening tools.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

What Are The Top Growth Drivers Impacting The Postpartum Depression Market Outlook?

The postpartum depression market is anticipated to expand due to an expected increase in postpartum depression cases. Postpartum depression is characterized by exaggerated worry that develops after giving birth, and it may also involve physical symptoms. Postnatal depression and postpartum anxiety frequently coexist, with symptoms potentially starting at any time within the first year after childbirth. The market’s growth is further driven by common treatments for postpartum depression, such as psychotherapy (also known as talk therapy or mental health counselling), medication, or a combination of both. For example, a survey of 1.1 million mothers conducted in February 2022 by the US-based University of Virginia School of Medicine (UVA SoM) revealed that first-time mothers, those under 25, and mothers of twins have the highest risk of postpartum depression. Among age groups, women aged 18-24 reported the highest rate of postpartum depression symptoms at 10%. Mothers of twins also reported higher rates, with 11.3% showing symptoms, compared to 8.3% of mothers with single children. Consequently, an increase in postpartum depression cases will propel the postpartum depression market.

What Are The Segment Types Shaping The Postpartum Depression Market?

The postpartum depressionmarket covered in this report is segmented –

1) By Types: Postpartum Blues; Postpartum Anxiety; Postpartum Obsessive Compulsive Disorder; Postpartum Panic Disorder; Postpartum Post-Traumatic Stress Disorder; Postpartum Psychosis; Other Types

2) By Treatment: Psychotherapy; Medication; Supplements; Other Treatments

3) By Route of Administration: Oral; Parenteral; Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels

5) End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances; Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD); Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts; Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks; Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth; Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations; Severe Mood Swings

7) By Other Types: Mixed Mood Disorders; Comorbid Conditions With Postpartum

How Are Emerging Market Trends Shaping The Postpartum Depression Industry Landscape?

Companies operating within the postpartum depression market are actively pursuing new product innovations to sustain their competitive position. The limited available treatment choices have intensified the need for advancements in faster-acting therapies and creative approaches to care delivery for postpartum depression. For instance, in February 2023, Biogen Inc., a US-based biotechnology company, and Sage Therapeutics Inc., a US-based biopharmaceutical company, announced that the United States Food and Drug Administration (FDA) accepted the filing of a new drug application (NDA) for zuranolone, intended for managing major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an experimental medication being investigated as a 14-day, once-daily, rapid-acting oral therapy for individuals with MDD and PPD. As a neuroactive steroid, zuranolone acts as a positive allosteric modulator of GABA-A receptors, which constitutes a unique method of action. It is believed to work in persons with depression by quickly resetting dysregulated neural networks to help restore brain function. Zuranolone impacts brain networks that govern mood, arousal, behavior, and even cognition.

Who Are The Top Performing Companies In The Postpartum Depression Market In Recent Years?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Which Regional Markets Are Contributing Most To The Postpartum Depression Industry Expansion?

North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Postpartum Depression Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

Browse Through More Reports Similar to the Global Postpartum Depression Market 2025, By The Business Research Company

Mental Health Apps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mental-health-apps-global-market-report

Behavioral And Mental Health Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Residential Substance Abuse And Mental Health Facilities Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Postpartum Depression Market?

The expected surge in instances of postpartum depression is projected to spur the expansion of the postpartum depression market. Intensified anxiety after childbirth, known as postpartum depression, can result in physical symptoms alongside regular ones. Commonly coexisting with postnatal depression and postpartum anxiety, these symptoms can manifest at any point within the first year post-childbirth. The prevalent treatments for postpartum depression are psychotherapy, also termed as talk therapy or mental health counseling, or medication, if not a combination of both. This is resulting in an upshot for the market. A survey in February 2022 conducted by the University of Virginia School of Medicine (UVA SoM), a medical school based in the US, found that postpartum depression risk is primarily high among first-time mothers, mothers below the age of 25, and those with twins. According to the age groups, 10% of women aged between 18-24 reported the highest rate of postpartum depression symptoms. Mothers of twins showed a higher rate (11.3%) of postpartum depression than those with single kids (8.3%). Hence, the surge in postpartum depression instances is projected to boost the market.

Justification for the Postpartum Depression Market’s Upsurge: An Increase in Birth Rates Propels the Market

 

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

#What Growth Opportunities Will Drive the Postpartum Depression Market’s CAGR Through 2034?

The market size of postpartum depression has seen substantial growth in the past few years. It’s set to expand from a value of $12.15 billion in 2024 to a significant $16.09 billion in 2025, showcasing a compound annual growth rate (CAGR) of 32.4%. The past period of growth can be credited to factors such as increased awareness on maternal mental health, strides in research, public health programs, and a rise in screenings.

It is anticipated that the market size for postpartum depression will witness a rapid expansion in the forthcoming years. The predicted growth will see the market hitting a value of $49.4 billion by 2029, with a compound annual growth rate (CAGR) of 32.4%. Such progression during the prediction period can be credited to factors like improvements in telehealth services, advancement in pharmacology, legislative actions on maternal mental health, and growth of the mental health workforce. The major trends projected to be seen during this period comprise of cohesive care models, peer support initiatives, perinatal mental health applications, and tools for mental health screening.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13024

What Are the Most Significant Market Trends Transforming thePostpartum Depression Market?

Firms in the postpartum depression market are focusing on producing innovative products to maintain their market standing. The lack of various treatment options has propelled the demand for more rapid and inventive therapeutic approaches and care provision for postpartum depression. Biogen Inc., and Sage Therapeutics Inc., two American biotech and biopharmaceutical firms, announced in February 2023 that the FDA has approved their NDA for zuranolone—a treatment for major depressive disorder (MDD) and postpartum depression (PPD). This new drug is monumental in that it’s being evaluated as a 14-day, once-daily, speedy-acting oral treatment for individuals with MDD and PPD. Zuranolone, a neuroactive steroid with a unique mechanism of action as a positive allosteric modulator of GABA-A receptors, is anticipated to work in depression sufferers by rapidly resetting dysfunctional neural connections to reinstate brain function. It influences brain networks responsible for mood, arousal, behavior, and cognition.

What Are the Top Market Players Propelling the Growth of thePostpartum Depression Industry?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Which Primary Segments of the Postpartum Depression Market Are Driving Growth and Industry Transformations?

The postpartum depression market covered in this report is segmented –

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types

2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings

7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Postpartum Depression Market?# Market?

North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Postpartum Depression Market 2025, By The Business Research Company:

Telepsychiatry Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report

Behavioral and Mental Health Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Residential Substance Abuse And Mental Health Facilities Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the postpartum depression market?

The postpartum depression market has experienced exponential growth, with forecasts indicating a rise from $12.15 billion in 2024 to $16.09 billion in 2025, at a CAGR of 32.4%. This growth has been fueled by increasing awareness of maternal mental health, advancements in research, public health initiatives, and enhanced screening programs.

What will be the postpartum depression market size in the future?

The postpartum depression market is set for exponential growth, soaring to $49.4 billion by 2029 with a CAGR of 32.4%. Growth factors include increasing telehealth services, pharmacological advancements, maternal mental health policies, and workforce expansion in mental healthcare. Major trends include integrated care models, peer support initiatives, perinatal mental health applications, and improved screening tools.

Get your postpartum depression market report here!

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

What main drivers are fueling expansion in the postpartum depression market?

Anticipated growth in the postpartum depression market is thought to be fueled by a surge in postpartum depression incidents. Postpartum depression represents intense post-birth concern, often supplemented by physical symptoms. Postnatal depression is commonly coincident with postpartum anxiety and can potentially start at any point during the first year post-birth. Both medication and psychotherapy, alternatively known as talk therapy or professional mental health counseling, or a combination of both are typically applied to treat postpartum depression, contributing to market growth. For instance, a February 2022 study involving 1.1 million mothers conducted by the US-based University of Virginia School of Medicine (UVA SoM) found the Risk of postpartum depression is greatest among new mothers, those under 25, and mothers of twins. Postpartum depression symptoms were reported by 10% of women aged 18-24, which was the highest across all age groups. Twin mothers presented slightly higher rates of postpartum depression at 11.3% as opposed to 8.3% for single-child mothers. Hence, the rising cases of postpartum depression are bolstering the postpartum depression market.

Postpartum Depression Market Propellant: Surge in Childbirth Numbers Fuels Growth

 

What key areas define the segmentation of the global postpartum depression market?

The postpartum depression market covered in this report is segmented –

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types

2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings

7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

Who are the dominant players expanding their reach in the postpartum depression market?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Viatris Inc., Northwell Health, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals PLC, Sage Therapeutics Inc.

How are evolving market trends shaping postpartum depression Strategies?

In the postpartum depression market, companies strive to remain competitive by consistently innovating new products. The currently limited options for treatment necessitate the development of therapies that act more rapidly and novel modes of care delivery for postpartum depression. For example, Biogen Inc. and Sage Therapeutics Inc., both American companies, one a biotech and the other a biopharmaceutical, declared in February 2023 that the FDA has given its acceptance for an NDA for their experimental drug, zuranolone, to combat major depressive disorder (MDD) and postpartum depression (PPD). The experimental drug, zuranolone, is being trialed as an everyday, 14-day, fast-acting oral treatment for those struggling with MDD and PPD. Zuranolone, a neuroactive hormone, works as a positive modulator for GABA-A receptors, which represents an unprecedented mechanism of action. The expectation is that it will address depression swiftly by restoring the brain networks that regulate mood, arousal, behavior, and also cognition, that have experienced significant disruption.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13024

Which regions are emerging as leaders in the postpartum depression market?

North America was the largest region in the postpartum depression market in 2024. The regions covered in postpartum depression market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Telepsychiatry Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/telepsychiatry-global-market-report

Behavioral and Mental Health Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Residential Substance Abuse And Mental Health Facilities Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/residential-substance-abuse-and-mental-health-facilities-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: